67978-05-6

Basic information

• Product Name: 4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-Methylethenyl)-3-(4-Methylphenyl)-7-oxo-, diphenylMethyl ester, [1R-[1α,5α,6(R*)]]- (9CI)
• Synonyms: 4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-Methylethenyl)-3-(4-Methylphenyl)-7-oxo-, diphenylMethyl ester, [1R-[1α,5α,6(R*)]]- (9CI);[1R-[1alpha,5alpha,6(R)]]-alpha-(1-methylethenyl)-3-(4-methylphenyl)-7-oxo-4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid diphenylmethyl ester;4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, a-(1-Methylethenyl)-3- (4-Methylphenyl)-7-oxo-, diphenylMethyl ester, [1R-[1a,5a,6(R*)]];4-Oxa-2,6-diazabicyclo 3.2.0 hept-2-ene-6-acetic acid, α-(1-Methylethenyl)-3-(4-;benzhydryl (R)-3-methyl-2-((1R,5S)-7-oxo-3-(p-tolyl)-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)but-3-enoate
• CAS NO: 67978-05-6
• Molecular Formula: C₂₉H₂₆N₂O₄
• Molecular Weight: 466.52774
• EINECS: -0
• Mol File: 67978-05-6.mol

Chemical Properties

• Boiling Point: 660.2±55.0 °C(Predicted)
• Appearance: /
• Density: 1.23±0.1 g/cm3 (20 ºC 760 Torr)
• PKA: 2.62±0.20(Predicted)
• CAS DataBase Reference: 4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-Methylethenyl)-3-(4-Methylphenyl)-7-oxo-, diphenylMethyl ester, [1R-[1α,5α,6(R*)]]- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-Methylethenyl)-3-(4-Methylphenyl)-7-oxo-, diphenylMethyl ester, [1R-[1α,5α,6(R*)]]- (9CI)(67978-05-6)
• EPA Substance Registry System: 4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-Methylethenyl)-3-(4-Methylphenyl)-7-oxo-, diphenylMethyl ester, [1R-[1α,5α,6(R*)]]- (9CI)(67978-05-6)

Safety Data

• Hazardous Substances Data: 67978-05-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-methylethenyl)-3-(4-methylphenyl)-7-oxo-, diphenylmethyl ester, [1R-[1α,5α,6(R)]](9CI) is used as a pharmaceutical research compound for its potential to contribute to the development of new drugs. Its complex structure and unique properties may offer novel therapeutic avenues in the treatment of various diseases.
Used in Chemical Research:
In the field of chemical research, 4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-methylethenyl)-3-(4-methylphenyl)-7-oxo-, diphenylmethyl ester, [1R-[1α,5α,6(R)]](9CI) serves as a valuable compound for studying its chemical behavior, reactivity, and potential use in the synthesis of other complex organic molecules. Its unique structure can provide insights into new chemical reactions and mechanisms.
Used in Drug Development:
4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-methylethenyl)-3-(4-methylphenyl)-7-oxo-, diphenylmethyl ester, [1R-[1α,5α,6(R)]](9CI) is utilized in drug development as a potential lead compound. Its complex molecular structure may possess bioactive properties that can be optimized and modified to create effective therapeutic agents for various medical conditions.
Used in Medicinal Chemistry:
In medicinal chemistry, 4-Oxa-2,6-diazabicyclo[3.2.0]hept-2-ene-6-acetic acid, α-(1-methylethenyl)-3-(4-methylphenyl)-7-oxo-, diphenylmethyl ester, [1R-[1α,5α,6(R)]](9CI) is employed as a compound of interest for the design and synthesis of novel pharmaceutical agents. Its unique features can be leveraged to develop molecules with improved pharmacological properties, such as increased potency, selectivity, and reduced side effects.

Upstream product

• 17028-66-9 6β-(4-toluamido)penicillanic acid 
• 82468-41-5 C₂₉H₂₈N₂O₅S 
• 91-01-0 1,1-Diphenylmethanol 
• 104101-66-8 diphenylmethyl 6β-(4-toluamido)penicillanate 
• 67977-95-1 diphenylmethyl 6β-(4-toluamido)penicillate 1-oxide 
• 551-16-6 6-Aminopenicillanic Acid 
• 874-60-2 4-methyl-benzoyl chloride 

Downstream Products

• 68313-81-5 diphenylmethyl (2R,6R,7R)-3-methylene-7-[(4-methylbenzoyl)amino]-8-oxo-5-oxa-1-azabicyclo[4.2.0]octane-2-carboxylate 
• 134237-56-2 (6R,7R)-benzhydryl (7-(2-difluoromethylthio)acetamido)-3-(chloromethyl)-7-methoxy-8-oxo-5-oxa-1-aza-bicyclo[4,2,0]oct-2-ene-2-carboxylate 
• 1370637-72-1 C₃₀H₂₆Cl₂N₂O₆S 
• 1370637-75-4 C₃₀H₂₅Cl₃N₂O₆S 
• 1370637-57-2 C₃₀H₂₈F₂N₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-79-8 C₃₃H₃₂F₂N₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-82-3 C₃₁H₂₈F₂N₅O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-86-7 C₃₅H₃₁ClN₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-89-0 C₃₈H₃₅ClN₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-91-4 C₃₆H₃₁ClN₅O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-94-7 C₃₅H₃₀Cl₂N₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-97-0 C₃₈H₃₄Cl₂N₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370638-00-8 C₃₆H₃₀Cl₂N₅O₆S⁽¹⁺⁾*I^(1-) 
• 91177-27-4 7-(N-4-methylbenzamide)-3-(chloromethyl)-8-oxo-5-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenylmethyl ester 

Relevant articles and documents

Preparation method of methylthiazoline

The invention provides a preparation method of methylthiazoline. According to the method, a one-pot-process low-temperature acylation esterification oxidation technology, an organic base catalysis chiral conversion technology, a desulfurization ring-opening synthesis technology, a comprehensive cyclic solvent utilization technology and a byproduct recycling technology are integrated, and the method is mature in technology, simple in synthesis process, few in reaction steps and low in raw material consumption and has the characteristics of good atom economy, good product quality and low cost.

Preparation method of cephalosporin intermediate

The invention discloses a preparation method of a cephalosporin intermediate. According to the preparation method, the cephalosporin intermediate is prepared by performing desulfurization reaction on(2S,5R,6S)-3,3-dimethyl-6-phenylformamide-4,7-dioxo-4-th

Design, synthesis and antibacterial activity of novel 1-oxacephem analogs

A series of 1-oxacephem analogs were synthesized and their antibacterial properties against five strains of Gram-positive and Gram-negative bacteria were evaluated in vitro while ceftazidine was selected as control. Some of the tested compounds, compound 12c in particular, showed more active against three selected strains than the standard.